Boston snaps up cardiac ablation developer
This article was originally published in Clinica
Executive Summary
AJust a week after its latest stock-swap acquisition, Boston Scientific has struck again. The Massachusetts-based minimally invasive device specialist has taken over EP Technologies in a swap valued at around $150 million. EP Technologies is one of only two companies with an FDA-approved cardiac ablation catheter, the other being Medtronic.